David J. Asper

Subcutaneous and intranasal immunization with type III secreted proteins can prevent colonization and shedding of Escherichia coli O157:H7 in mice

Shawn Babiuk, David J. Asper, Dragan Rogan et al. · Microbial Pathogenesis · 2008 · 56 citations

Life Sciences, Immunology, Microbiology +16

Vaccination with type III secreted proteins leads to decreased shedding in calves after experimental infection with Escherichia coli O157.

Kevin J. Allen, Dragan Rogan, B. Brett Finlay et al. · PubMed · 2011 · 39 citations · Full text

Veterinary Medicine, Immunology, Veterinary Microbiology +15

Serological Response of Shiga Toxin-Producing Escherichia coli Type III Secreted Proteins in Sera from Vaccinated Rabbits, Naturally Infected Cattle, and Humans

David J. Asper, Mohamed A. Karmali, Hugh G.G. Townsend et al. · Clinical and Vaccine Immunology · 2011 · 34 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Cross reactivity of enterohemorrhagic Escherichia coli O157:H7-specific sera with non-O157 serotypes

David J. Asper, Inna Sekirov, B. Brett Finlay et al. · Vaccine · 2007 · 26 citations

Life Sciences, Immunology, Microbiology +14

The role of Tir, EspA, and NleB in the colonization of cattle by Shiga toxin producing<i>Escherichia coli</i>O26:H11

O. Yu. Misyurina, David J. Asper, Wanyin Deng et al. · Canadian Journal of Microbiology · 2010 · 17 citations

Life Sciences, Molecular Biology, Veterinary Microbiology +16